Displaying items 13-15 of 15
» View ktuu.com items only
< Previous
1
2
-
For Diabetes Drug Avandia, Bad News Continues
Los Angeles TimesThe diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....Tags: Health, Government Health Care, Healthcare Provider, Pharmaceuticals, Hospitals and Clinics
-
The Avandia Dilemma
Staff WriterThe arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Drug safety...Tags: Health, Diseases and Illnesses, Colleges and Universities, Pharmaceuticals, Hospitals and Clinics
-
FDA: Avandia Should Stay With Restrictions
Los Angeles TimesFaced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...Tags: Health, IMS Health Incorporated, Pharmaceuticals, Insulin, Hospitals and Clinics
Jun 29, 2010
|Story| Los Angeles Times
Jun 30, 2010
|Story| Health Portal
Jul 15, 2010
|Story| Los Angeles Times
Original site for Actos (drug) topic gallery.